Biopharmaceutics modeling and simulations : theory, practice, methods, and applications /

BA comprehensive introduction to using modeling and simulation programs in drug discovery and development/b/ Biopharmaceutical modeling has become integral to the design and development of new drugs. Influencing key aspects of the development process, including drug substance design, formulation des...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας: Sugano, Kiyohiko
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Hoboken, N.J. : John Wiley & Sons, [2013]
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 05098nam a2200733 4500
001 ocn778314813
003 OCoLC
005 20170124072729.6
006 m o d
007 cr cn|||||||||
008 120224s2013 nju ob 001 0 eng
010 |a  2012008118 
040 |a DLC  |b eng  |e pn  |c DLC  |d DG1  |d CDX  |d COO  |d IDEBK  |d RECBK  |d TEFOD  |d UKDOC  |d NLGGC  |d YDXCP  |d TEFOD  |d OCLCQ  |d OCLCO  |d OCLCQ  |d DEBBG  |d OCLCQ  |d GrThAP 
019 |a 809247093  |a 864910965 
020 |a 9781118354315  |q (pdf) 
020 |a 1118354311  |q (pdf) 
020 |a 9781118354322  |q (epub) 
020 |a 111835432X  |q (epub) 
020 |a 9781118354308  |q (mobi) 
020 |a 1118354303  |q (mobi) 
020 |a 9781118354339  |q (electronic bk.) 
020 |a 1118354338  |q (electronic bk.) 
020 |z 9781118028681  |q (cloth) 
020 |z 9781118188330  |q (cloth) 
020 |z 1118028686 
020 |z 1118188330 
020 |z 9781299314597 
020 |z 1299314597 
028 0 1 |a EB00063416  |b Recorded Books 
029 1 |a AU@  |b 000048630417 
029 1 |a DEBBG  |b BV041906098 
029 1 |a NZ1  |b 15921985 
029 1 |a DEBBG  |b BV043394252 
035 |a (OCoLC)778314813  |z (OCoLC)809247093  |z (OCoLC)864910965 
037 |a 10.1002/9781118354339  |b Wiley InterScience  |n http://www3.interscience.wiley.com 
037 |a 34CA8DE4-B045-4FBD-9A56-87EE0BA622FE  |b OverDrive, Inc.  |n http://www.overdrive.com 
042 |a pcc 
050 0 0 |a QV38 
060 1 0 |a QV 38 
082 0 0 |a 615.7  |2 23 
049 |a MAIN 
100 1 |a Sugano, Kiyohiko. 
245 1 0 |a Biopharmaceutics modeling and simulations :  |b theory, practice, methods, and applications /  |c Kiyohiko Sugano. 
264 1 |a Hoboken, N.J. :  |b John Wiley & Sons,  |c [2013] 
264 4 |c ©2013 
300 |a 1 online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
505 0 |a Introduction -- Theoretical framework I : solubility -- Theoretical framework II : dissolution -- Theoretical framework III : biological membrane permeation -- Theoretical framework IV : gastrointestinal transit models and integration -- Physiology of gastrointestinal tract and other administration sites in humans and animals -- Drug parameters -- Validation of mechanistic models -- Bioequivalence and biopharmaceutical classification system -- Dose and particle size dependency -- Enabling formulations -- Food effect -- Biopharmaceutical modeling for miscellaneous cases -- Intestinal transporters -- Strategy in drug discovery and development -- Epistemology of biopharmaceutical modeling and good simulation practice. 
588 0 |a Print version record and CIP data provided by publisher. 
520 |a BA comprehensive introduction to using modeling and simulation programs in drug discovery and development/b/ Biopharmaceutical modeling has become integral to the design and development of new drugs. Influencing key aspects of the development process, including drug substance design, formulation design, and toxicological exposure assessment, biopharmaceutical modeling is now seen as the linchpin to a drug's future success. And while there are a number of commercially available software programs for drug modeling, there has not been a single resource guiding pharmaceutical professionals to the actual tools and practices needed to design and test safe drugs./ A guide to the basics of modeling and simulation programs, iBiopharmaceutics Modeling and Simulations/i offers pharmaceutical scientists the keys to understanding how they work and are applied in creating drugs with desired medicinal properties. Beginning with a focus on the oral absorption of drugs, the book discusses:/ ulliThe central dogma of oral drug absorption (the interplay of dissolution, solubility, and permeability of a drug), which forms the basis of the biopharmaceutical classification system (BCS)/liliThe concept of drug concentration/liliHow to simulate key drug absorption processes/liliThe physiological and drug property data used for biopharmaceutical modeling/liliReliable practices for reporting results/li/ul With over 200 figures and illustrations and a peerless examination of all the key aspects of drug research'including running and interpreting models, validation, and compound and formulation selection'this reference seamlessly brings together the proven practical approaches essential to developing the safe and effective medicines of tomorrow. 
650 0 |a Biopharmaceutics  |x Computer simulation. 
650 2 |a Biopharmaceutics  |x methods. 
650 2 |a Computer Simulation. 
650 2 |a Drug Compounding  |x methods. 
650 2 |a Models, Theoretical. 
650 4 |a Medical. 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
655 4 |a Electronic books. 
776 0 8 |i Print version:  |a Sugano, Kiyohiko.  |t Biopharmaceutics modeling and simulations.  |d Hoboken, N.J. : John Wiley & Sons, ©2013  |z 9781118028681  |w (DLC) 2012007296 
856 4 0 |u https://doi.org/10.1002/9781118354339  |z Full Text via HEAL-Link 
994 |a 92  |b DG1